University of Minnesota College of Science and Engineering

Polymer ‘wafers’ placed under the tongue could deliver vaccines of the future

Researchers create new way to effectively deliver and preserve vaccines

Newswise — MINNEAPOLIS / ST. PAUL (5/26/2021) – A team of researchers, led by a University of Minnesota associate professor, have developed a polymer “wafer” that, when placed under the tongue, can effectively deliver and preserve protein-based vaccines for diseases. The research could open the door for vaccines that can be more easily produced and distributed to communities around the world. 

The study is published in the Journal of Controlled Release, a biweekly peer-reviewed medical journal.

The membrane under the tongue—called the sublingual site—has proven to be very effective at absorbing drugs. Several drugs are delivered this way, such as nitroglycerin tablets to treat chest pain that precedes heart attacks. But large molecules, such as the proteins and nucleic acids that make up many vaccines, have historically been too big to enter the body sublingually and have to be injected with needles. These large molecules are also very fragile and must be preserved, which can be a roadblock for vaccine distribution—for example, Pfizer’s COVID-19 vaccine, which is made up of nucleic acids and requires ultra-cold storage.

With the polymer wafers, the researchers have found a solution to both of those problems—and proven that their technology works with human immunodeficiency virus (HIV) proteins. While there is not a working vaccine for HIV yet, the researchers have demonstrated a delivery method that could work once one is developed.

“People have been struggling with creating an HIV vaccine for many years, and one of the problems is how to deliver it,” said Chun Wang, corresponding author of the study and a biomedical engineering associate professor in the University of Minnesota’s College of Science and Engineering. “So the challenge becomes, can we take a large molecule like a protein, store it at room temperature, give it through the sublingual site, avoid the pain and hassle with needles, have it be absorbed, and actually generate an immune response? And it turns out that we have demonstrated it actually can work with a rather simple but elegant material platform.”

The wafer is mainly made up of two ingredients: alginate and carboxymethyl cellulose (CMC). The alginate preserves the proteins while the CMC helps the wafer stick to the sublingual membrane long enough to deliver a high concentration of the proteins. The key to making the wafer work, Wang said, was finding the right balance of the two polymers. 

With further testing, the polymer wafers could also provide avenues for other vaccines—perhaps one day, for COVID-19. 

“This is just a small step in this long journey,” Wang said. “If we continue this line of work, it can bring us to a point where we will have vaccines—they could be based on DNA, RNA, proteins—that can be stored without refrigeration and easily delivered under the tongue at the sublingual site. They will be quickly disseminated throughout the world because they don’t rely on certain equipment and preservation and all of that stuff. This will be particularly good for low-resource regions of the world, even in America—rural areas that are lacking certain essential facilities and infrastructure.”

In addition to Wang, the research team included University of Minnesota College of Science and Engineering alumni Sam Hanson and Anthony Tabet; Michael Barry, a professor at the Mayo Clinic; Jagannadha Sastry, a professor at the University of Texas’ MD Anderson Cancer Center; and Shailbala Singh, a researcher at the MD Anderson Cancer Center.

The research was funded by a grant from the Minnesota Partnership for Biotechnology and Medical Genomics. Parts of the work were carried out in the University of Minnesota’s Characterization Facility, which receives partial support through the National Science Foundation-funded Materials Research Science and Engineering Centers (MRSEC) at the University of Minnesota.

To read the research paper entitled “Mucoadhesive wafers composed of binary polymer blends for sublingual delivery and preservation of protein vaccines,” visit the ScienceDirect website.

SEE ORIGINAL STUDY



Filters close

Showing results

110 of 6123
Released: 4-Aug-2021 5:05 PM EDT
Canadian-Led International Study: Full-Dose Blood Thinners Benefit Moderately Ill COVID-19 Patients
University of Manitoba

The investigators discovered that in moderately ill patients full-dose heparin reduced the need for organ support compared to those who received lower-dose heparin.

Released: 4-Aug-2021 4:00 PM EDT
CDC withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test does not mean the test failed
Newswise

Social media is now rife with claims about why the CDC is withdrawing its request for emergency use authorization for its COVID-19 PCR diagnostic test after December 2021.

Newswise: Public
Released: 4-Aug-2021 2:05 PM EDT
A Study Reveals What Triggers Lung Damage During COVID-19
The Korea Advanced Institute of Science and Technology (KAIST)

A KAIST immunology research team found that a specific subtype of macrophages that originated from blood monocytes plays a key role in the hyper-inflammatory response in SARS-CoV-2 infected lungs, by performing single-cell RNA sequencing of bronchoalveolar lavage fluid cells.

Released: 4-Aug-2021 1:00 PM EDT
American Society of Anesthesiologists and Anesthesia Patient Safety Foundation Say Preoperative Testing for COVID-19 is Essential, Regardless of Vaccination
American Society of Anesthesiologists (ASA)

All patients undergoing non-emergency surgeries or procedures should continue to have preoperative polymerase chain reaction (PCR) testing for SARS-CoV-2, irrespective of vaccination status, according to an updated guidance from the American Society of Anesthesiologists and Anesthesia Patient Safety Foundation.

Newswise: FAU Expert Answers Questions about Delta Variant, Vaccines and Public Safety
Released: 4-Aug-2021 12:35 PM EDT
FAU Expert Answers Questions about Delta Variant, Vaccines and Public Safety
Florida Atlantic University

Florida Atlantic University’s Joanna Drowos, D.O., M.P.H., M.B.A., Schmidt College of Medicine, provides answers to some of the most frequently asked questions regarding the COVID-19 Delta variant, vaccines and public safety measures.

Released: 4-Aug-2021 11:15 AM EDT
Rehabilitation Nurses Play Critical Role in Treating Patients with Long-Term Covid-19 Symptoms
Association of Rehabilitation Nurses

A new and free webinar from the Association of Rehabilitation Nurses (ARN) and the American Nurses Association (ANA) features advice from rehabilitation nurses to the greater nursing community about care priorities and interventions for long haul COVID-19 patients.

Newswise:Video Embedded spreading-doses-of-hope-as-covid-19-cases-rise
VIDEO
Released: 4-Aug-2021 10:35 AM EDT
Spreading ‘Doses of Hope’ as COVID-19 Cases Rise
Cedars-Sinai

In an emotional new series of videos, Black medical professionals plead for viewers to get a COVID-19 vaccine.

Newswise:Video Embedded american-college-of-surgeons-urges-surgeons-to-talk-it-up-with-patients-about-covid-19-vaccination
VIDEO
Released: 4-Aug-2021 10:00 AM EDT
American College of Surgeons Urges Surgeons to “Talk It Up” with Patients About COVID-19 Vaccination
American College of Surgeons (ACS)

ACS is launching a “Talk It Up” campaign to help surgeons address patient concerns and help them understand the importance of getting vaccinated against COVID-19.

28-Jul-2021 11:15 AM EDT
LEDs Light the Way to Coronavirus Disinfection
American Institute of Physics (AIP)

LEDs are commonly used for sterilization, and in the continued effort to combat the coronavirus pandemic, LEDs can also help inactivate SARS-CoV-2. A team in Pakistan designed far-ultraviolet LEDs at a targeted wavelength of 222 nanometers, chosen both for its ability to inactivate the virus and for being safe on human skin. They based their design on the material aluminum gallium nitride, part of a set of materials called III-nitrides which are efficient, inexpensive, and environmentally friendly.


Showing results

110 of 6123

close
1.4172